Biodel

Biodel is a biopharmaceutical company focused on the development and commercialization of diabetes treatments. It develops its product candidates by applying its formulation technology to existing drugs, with Linjeta being one of its products. Linjeta is formulated as a fast-acting mealtime insulin for the treatment of patients with Type I and Type II diabetes.